Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Paul J. Lytle currently holds 1,641,252 shares of ACTUATE THERAPEUTICS, INC. (ACTU), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul J. Lytle has been a net buyer of ACTU stock. They have purchased $25.5K and sold $0 worth of shares.
Paul J. Lytle's most recent insider trade was on Aug 14, 2024, when they sold 234,971 shares at $0.00 per share.
Paul J. Lytle serves as Executive at ACTUATE THERAPEUTICS, INC. (ACTU). They have executed 25 insider transactions totaling $25.5K over their tenure at the company.
Paul J. Lytle holds the position of Executive at ACTUATE THERAPEUTICS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Paul J. Lytle has shown a buying trading pattern, with $25.5K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Paul J. Lytle was on Jun 11, 2007, when they sold $18.0K worth of PPHM shares. This transaction involved 30,000 shares at $0.60 per share.
Paul J. Lytle currently owns 1,641,252 shares of ACTUATE THERAPEUTICS, INC. (ACTU), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Paul J. Lytle's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Paul J. Lytle has 25 Form 4 filings on record as an insider at ACTUATE THERAPEUTICS, INC..
Set alerts for Paul J. Lytle and 40,000+ other insiders.